US Patent 6849639 Integrin inhibitors and their methods of use
Patent 6849639 was granted and assigned to Amgen on February, 2005 by the United States Patent and Trademark Office.
All edits
Edits on 6 Nov, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+20 properties)
Article (+598 characters)
Article
Patent abstract
The invention comprises novel compounds that are effective in the prophylaxis and treatment of diseases, such as integrin receptors mediated diseases, in particular, diseases or conditions mediated by integrin receptors, such as a αvβ3, αvβ5, αvβ6, α5β1 and the like. The invention encompasses novel compounds, pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of such diseases and disorders. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Aaron Siegmund0
Alexander Kiselyov0
Celia Dominguez0
Guoqing Chen0
Longbin Liu0
Michael Handley0
Nianhe Han0
Ning Xi0
Qi Huang0
Qingyian Liu0
Shimin Xu0
Date of Patent
February 1, 2005
0Patent Application Number
097325460
Date Filed
December 8, 2000
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 6849639 Integrin inhibitors and their methods of use
Find more entities like US Patent 6849639 Integrin inhibitors and their methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
